Arformoterol
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391747This classification denotes a beta-adrenergic agonist with the molecular formula C19H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, F91H02EBWT chemically known as formamide, n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) but generally known as arformoterol, which bears US NIH Compound Identifier 3083544. European Medicines Agency schedules Arformoterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35021. The term ARFORMOTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, no. 3, 2004, list 52). Most nations schedule arformoterol under HS 29242995 and SITC 51479. As of Q4 2014, ARFORMOTEROL remains the US FDA Preferred Term for this commodity. Arformoterol bears US NLM identifiers UMLS ID C0969589 and NCI Concept Code C61641. SMILES: CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.